Patents by Inventor Kishor Bhatia

Kishor Bhatia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Treating Blood Cancers
    Publication number: 20240082181
    Abstract: A method for treating a subject in need thereof having a bone or blood cancer, or a cancer that metastasizes to bone that includes administering to the subject an effective amount of hydroxyureamethyl acylfulvene.
    Type: Application
    Filed: November 1, 2023
    Publication date: March 14, 2024
    Applicant: Lantern Pharma Inc.
    Inventors: Jianli Zhou, Kishor Bhatia, Aditya Kulkarni
  • Method for treating rhabdoid tumors
    Patent number: 11844772
    Abstract: The methods include treating atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene. Some embodiments relate to treatment of atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene to a population or subject expressing SMARCB1.
    Type: Grant
    Filed: December 29, 2021
    Date of Patent: December 19, 2023
    Inventors: Kishor Bhatia, Aditya Kulkarni
  • METHOD FOR TREATING RHABDOID TUMORS
    Publication number: 20230321015
    Abstract: The methods include treating atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene. Some embodiments relate to treatment of atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene to a population or subject expressing SMARCB1.
    Type: Application
    Filed: December 29, 2021
    Publication date: October 12, 2023
    Inventors: Kishor Bhatia, Aditya Kulkarni
  • CANCER DRUG SENSITIVITY DETERMINING MARKERS
    Publication number: 20230304104
    Abstract: This application relates to markers for use in the determination of the sensitivity of a cancer patient to an anti-cancer agent (e.g., illudins/illudin analogs) to be administered thereto, which markers can determine whether or not the cancer of the patient has a therapeutic response to the anti-cancer agent, and to application of the markers.
    Type: Application
    Filed: May 18, 2023
    Publication date: September 28, 2023
    Inventors: Kishor Bhatia, Aditya Kulkarni
  • Method for Determining Sensitivity to 2,2'-Dithio-bis-Ethane Sulfonate
    Publication number: 20230220481
    Abstract: A method for treating cancer in a patient in which a sample of the tumor or cancer is obtained from the patient and screened for responsiveness to 2,2?-dithio-bis-ethane sulfonate analogs. The sample is treated with 2,2?-dithio-bis-ethane sulfonate analogs to determine whether one or more of a plurality of biomarkers will be expressed therein.
    Type: Application
    Filed: July 11, 2022
    Publication date: July 13, 2023
    Inventors: Aditya Kulkarni, Kishor Bhatia
  • Hydroxyureamethyl-Acylfulvene for Treating Brain Cancer or CNS Cancer
    Publication number: 20230181499
    Abstract: Methods for treating brain tumor cancer by administration hydroxyureamethyl-acylfulvene. Some embodiments relate to treatment of glioblastoma by administration of hydroxyureamethyl-acylfulvene. Method also includes characterizing the subtype and genetics of the markers.
    Type: Application
    Filed: April 12, 2021
    Publication date: June 15, 2023
    Inventors: Aditya Kulkarni, Kishor Bhatia
  • Method For Treating Pancreatic Cancer
    Publication number: 20230172882
    Abstract: Methods for treating pancreatic cancer by administration hydroxyureamethyl acylfulvene. Some embodiments relate to treatment of pancreatic cancer by administration of hydroxyureamethyl acylfulvene.
    Type: Application
    Filed: May 10, 2021
    Publication date: June 8, 2023
    Inventors: Aditya Kulkarni, Kishor Bhatia
  • Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
    Patent number: 5272057
    Abstract: The invention relates to a method for detecting the presence of a DNA polymorphism associated with predisposition for certain cancers in a human. This method involves analyzing the human chromosome 13 using a hybridization probe which will hybridize to the gene for human poly (ADP-ribose) polymerase wherein the probe is capable of identifying the DNA polymorphism.
    Type: Grant
    Filed: October 14, 1988
    Date of Patent: December 21, 1993
    Assignee: Georgetown University
    Inventors: Mark E. Smulson, Kishor Bhatia, Konrad Huppi